Viewing Study NCT03362502

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:43 AM
Ignite Modification Date: 2026-01-29 @ 5:27 PM
Study NCT ID: NCT03362502
Status: TERMINATED
Last Update Posted: 2025-09-15
First Post: 2017-11-29
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study to Evaluate the Safety and Tolerability of PF-06939926 Gene Therapy in Duchenne Muscular Dystrophy
Sponsor: Pfizer
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Duchenne Muscular Dystrophy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None gene therapy View
None mini-dystrophin View
None AAV View
None fordadistrogene movaparvovec View